Haslemo, T., Eliasson, E., Jukić, M. M., Ingelman‐Sundberg, M., & Molden, E. (2018). Significantly lower CYP2D6 metabolism measured as the O/N‐desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: A study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients. Br J Clin Pharmacol.

Haslemo, Tore, Erik Eliasson, Marin M. Jukić, Magnus Ingelman‐Sundberg, ja Espen Molden. "Significantly Lower CYP2D6 Metabolism Measured As the O/N‐desmethylvenlafaxine Metabolic Ratio in Carriers of CYP2D6*41 Versus CYP2D6*9 or CYP2D6*10: A Study On Therapeutic Drug Monitoring Data From 1003 Genotyped Scandinavian Patients." Br J Clin Pharmacol 2018.

Haslemo, Tore, et al. "Significantly Lower CYP2D6 Metabolism Measured As the O/N‐desmethylvenlafaxine Metabolic Ratio in Carriers of CYP2D6*41 Versus CYP2D6*9 or CYP2D6*10: A Study On Therapeutic Drug Monitoring Data From 1003 Genotyped Scandinavian Patients." Br J Clin Pharmacol 2018.